As to clauses/warranties; from the Exhibit in the

As to clauses/warranties; from the Exhibit in the 10-Q

(e) There is no pending, completed or, to Vyera’s Knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or
regulatory proceeding, charge, complaint, or investigation) against Vyera or any of its Affiliates that would reasonably be expected to have a
material adverse effect on Vyera’s ability to meet its obligations under this Agreement. None of Vyera or any of its Affiliates have received
any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the premarket
clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of,
or the labeling and promotion of any pharmaceutical product, (ii) enters or proposes to enter into a consent decree with Vyera or any of its
Affiliates, (iii) enjoins or prohibits Vyera or any of its Affiliates from undertaking Commercialization activities, or (iv) otherwise alleges any
material violation of any Applicable Laws by Vyera or any of its Affiliates. The properties, business and operations of Vyera have been and
are being conducted in all material respects in accordance with all Applicable Laws.